ISSN: 1758-4272
Journal Home
Journal Guideline
International Journal of Clinical Rheumatology Q4 Unclaimed
International Journal of Clinical Rheumatology is a journal indexed in SJR in Rheumatology with an H index of 17. It has a best quartile of Q4.
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
-
SJR Impact factor17
H Index0
Total Docs (Last Year)1
Total Docs (3 years)0
Total Refs0
Total Cites (3 years)1
Citable Docs (3 years)0
Cites/Doc (2 years)0.0
Ref/DocOther journals with similar parameters
Zeitschrift für Rheumatologie Q4
Open Rheumatology Journal Q4
Acta Reumatologica Portuguesa Q4
Nauchno-Prakticheskaya Revmatologiya Q4
Indian Journal of Rheumatology Q4
Compare this journals
Aims and Scope
Best articles by citations
The FRAX®: critical appraisal
View moreThyroid disorders, hyperprolactinemia and systemic lupus erythematosus activity
View moreIL-17 in primary knee osteoarthritis and its relation with severity of the disease
View moreGenetics of the type I interferon pathway in systemic lupus erythematosus
View moreUpdate on the treatment of myositis
View moreSleep disturbance in lupus patients
View moreClinical aspects of rheumatoid arthritis: highlights from the 2010 ACR conference
View moreEndomorphins in rheumatoid arthritis, osteoarthritis and experimental arthritis: clinical prospects
View moreWhat impact do race and ethnicity have on lupus mortality?
View moreImproved clinical outcomes and physical activity in patients with rheumatoid arthritis treated with originator adalimumab in routine clinical practice
View moreTechnology applications to improve health outcomes and self-management in patients with arthritis
View moreAcademic Health Science Networks: a new approach for driving health innovation
View moreSystemic lupus erythematosus diagnostics in the 'omics' era
View moreIL-6 is a critical cytokine for inflammatory bone loss in rheumatoid arthritis
View moreStatin therapy for targeting cardiovascular risk in rheumatoid arthritis
View moreOsteopenia: is it a problem?
View moreUse of bisphosphonates in the treatment of pediatric osteoporosis
View moreMilnacipran, a serotonin and norepinephrine reuptake inhibitor: a novel treatment for fibromyalgia
View moreTemporomandibular joint arthritis in juvenile idiopathic arthritis: the last frontier
View moreHot topics from the 4th International Conference on Osteoporosis in Men
View moreCircadian variation in plasma IL-6 and the role of modified-release prednisone in polymyalgia rheumatica
View moreRole of the Lyn tyrosine kinase in the development of autoimmune disease
View moreMetabolic abnormality and the proinflammatory state following hip joint surgery
View moreImpact of obesity on rheumatoid arthritis: Relation with disease activity, joint damage, functional impairment and response to therapy
View more
Comments